What happened with LNZA today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
LanzaTech Global helps industrial companies make products from gases released by steel mills, ferroalloy plants and refineries. Its process treats the gases, feeds them to microbes and recovers ethanol and other products from fermentation. The technology is already deployed at commercial plants in China, India and Belgium.
Partners generally own and operate the plants. They pay LanzaTech for technology licenses, engineering and related services, then provide opportunities for recurring royalties, microbe sales and software support. Licensing and engineering services together account for most revenue. LanzaTech also sells CarbonSmart products and takes minority ownership stakes in selected projects it co-develops.
The business depends on partners funding and operating plants, a reliable supply of suitable feed gas, and the prices partners can obtain for their products, which affect royalties. Revenue is concentrated among a small group of customers, with one contracting entity supplying a substantial share. The Shougang Joint Venture is particularly important to deployment in China: entities it controls operate several commercial ethanol plants, and it holds exclusive rights to use specified technology there for ethanol made from steel, iron and ferroalloy manufacturing by-products.
LanzaTech also owns a non-controlling stake in LanzaJet, which is developing commercial production of sustainable aviation fuel. LanzaJet holds an exclusive license to specified ethanol-to-fuel technology; outside existing exceptions, LanzaTech needs its consent to pursue new aviation-fuel opportunities using that technology. Deployment also requires jurisdiction-specific approvals for new production pathways and the import or use of genetically modified microbes.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
LanzaTech’s results depend on commercial technology deployments and licensing, making unlisted LanzaJet a key company to watch given LanzaTech’s substantial equity stake and $8.5 million in 2025 sublicensing revenue from it.
Gevo, Inc. competes for renewable-fuel developers’ technology spending with the sustainable aviation fuel technology commercialized through LanzaTech’s substantial investment in LanzaJet. Gevo licenses developers a process for turning alcohol into jet fuel; its licensing progress shows the competition facing that part of LanzaTech’s business.
Verde Clean Fuels, Inc. offers fuel-plant developers an alternative to LanzaTech’s gas-conversion technology and engineering services: Verde turns gas into liquid fuels, while LanzaTech uses microbes to turn gas into ethanol and other products. Watch whether Verde’s planned licensing and services for plant owners generate revenue—it had earned none from its principal business activities as of December 31, 2025.
XCF Global, Inc. exposes LanzaTech to the same investment in sustainable aviation fuel capacity and demand for low-carbon jet fuel, but also competes with fuel made through LanzaJet, which pays LanzaTech for technology licensing. XCF develops production facilities and plans to earn mainly from fuel sales, so its plant development and SAF sales are worth watching for competing supply.
LanzaTech Global, Inc. earningsThis company
LanzaTech's report will show whether licensing and CarbonSmart product sales can replace completed engineering and development projects with steadier revenue.
Read licensing revenue and CarbonSmart product sales alongside engineering and other services, joint development agreement (JDA) revenue, and cost of revenue. Growth in the first two, with project revenue stabilizing and costs not rising just as fast, would show commercialization broadening; if growth still depends on a few license or product deals while services and JDA revenue fall, or costs rise faster, the revenue base is not yet steady and greater scale is not improving the economics.
Gevo, Inc. earningsGEVO
Gevo's report will show whether developers are still spending on alcohol-to-jet technology that competes with LanzaJet's route using LanzaTech technology.
Look for progress in Gevo's technology licensing, not just its profit. Licensing progress or related revenue would show developers committing resources to another alcohol-to-jet route, strengthening competition as LanzaJet seeks technology opportunities; limited progress would suggest less pressure, but would not prove stronger demand for LanzaJet licenses or fuel.
